These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 31045647)

  • 1. No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART.
    Ward AR; Thomas AS; Stevenson EM; Huang SH; Keating SM; Gandhi RT; McMahon DK; Bosch RJ; Macatangay BJ; Cyktor JC; Eron JJ; Mellors JW; Jones RB;
    AIDS; 2022 Oct; 36(12):1617-1628. PubMed ID: 35730388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
    Crowell TA; Ritz J; Zheng L; Naqvi A; Cyktor JC; Puleo J; Clagett B; Lama JR; Kanyama C; Little SJ; Cohn SE; Riddler SA; Collier AC; Heath SL; Tantivitayakul P; Grinsztejn B; Arduino RC; Rooney JF; van Zyl GU; Coombs RW; Fox L; Ananworanich J; Eron JJ; Sieg SF; Mellors JW; Daar ES;
    AIDS; 2024 Jul; 38(8):1141-1152. PubMed ID: 38489580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV.
    Palma P; McManus M; Cotugno N; Rocca S; Rossi P; Luzuriaga K
    Lancet HIV; 2020 May; 7(5):e359-e365. PubMed ID: 32386722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.
    Lau JSY; McMahon JH; Gubser C; Solomon A; Chiu CYH; Dantanarayana A; Chea S; Tennakoon S; Zerbato JM; Garlick J; Morcilla V; Palmer S; Lewin SR; Rasmussen TA
    AIDS; 2021 Aug; 35(10):1631-1636. PubMed ID: 33859108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8
    Takata H; Mitchell JL; Pacheco J; Pagliuzza A; Pinyakorn S; Buranapraditkun S; Sacdalan C; Leyre L; Nathanson S; Kakazu JC; Intasan J; Prueksakaew P; Chomchey N; Phanuphak N; de Souza M; Haddad EK; Rolland M; Tovanabutra S; Vasan S; Hsu DC; Chomont N; Trautmann L; ;
    Cell Host Microbe; 2023 Sep; 31(9):1494-1506.e4. PubMed ID: 37708852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4
    Dubé M; Tastet O; Dufour C; Sannier G; Brassard N; Delgado GG; Pagliuzza A; Richard C; Nayrac M; Routy JP; Prat A; Estes JD; Fromentin R; Chomont N; Kaufmann DE
    Cell Host Microbe; 2023 Sep; 31(9):1507-1522.e5. PubMed ID: 37708853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1.
    Nelson AN; Dennis M; Mangold JF; Li K; Saha PT; Cronin K; Cross KA; Kumar A; Mangan RJ; Shaw GM; Bar KJ; Haynes B; Moody AM; Munir Alam S; Pollara J; Hudgens MG; Van Rompay KKA; De Paris K; Permar SR
    NPJ Vaccines; 2022 Jul; 7(1):87. PubMed ID: 35907918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV.
    Calvet-Mirabent M; Sánchez-Cerrillo I; Martín-Cófreces N; Martínez-Fleta P; de la Fuente H; Tsukalov I; Delgado-Arévalo C; Calzada MJ; de Los Santos I; Sanz J; García-Fraile L; Sánchez-Madrid F; Alfranca A; Muñoz-Fernández MÁ; Buzón MJ; Martín-Gayo E
    EBioMedicine; 2022 Jul; 81():104090. PubMed ID: 35665682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Combination Antiretroviral Therapy on HIV-1 Serological Responses and Their Implications: A Systematic Review and Meta-Analysis.
    Liang Y; Lin H; Dzakah EE; Tang S
    Front Immunol; 2022; 13():844023. PubMed ID: 35432309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1.
    Matavele Chissumba R; Magul C; Macamo R; Monteiro V; Enosse M; Macicame I; Cumbane V; Bhatt N; Viegas E; Imbach M; Eller LA; Polyak CS; Kestens L;
    BMC Immunol; 2022 Mar; 23(1):12. PubMed ID: 35287587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients.
    Ivison GT; Vendrame E; Martínez-Colón GJ; Ranganath T; Vergara R; Zhao NQ; Martin MP; Bendall SC; Carrington M; Cyktor JC; McMahon DK; Eron J; Jones RB; Mellors JW; Bosch RJ; Gandhi RT; Holmes S; Blish CA;
    Front Cell Infect Microbiol; 2022; 12():757846. PubMed ID: 35223535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unconventional CD45RA+ memory CD8 T cells to control HIV infection during antiretroviral therapy.
    Rolot M; Dewals BG
    Cell Mol Immunol; 2020 Sep; 17(9):897-898. PubMed ID: 32503999
    [No Abstract]   [Full Text] [Related]  

  • 13. Have Cells Harboring the HIV Reservoir Been Immunoedited?
    Huang SH; McCann CD; Mota TM; Wang C; Lipkin SM; Jones RB
    Front Immunol; 2019; 10():1842. PubMed ID: 31447850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses.
    Keating SM; Jones RB; Lalama CM; Bosch RJ; McMahon D; Hampton D; Cyktor J; Eron JJ; Mellors JW; Busch MP; Gandhi RT;
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):594-599. PubMed ID: 31045647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.
    Thomas AS; Jones KL; Gandhi RT; McMahon DK; Cyktor JC; Chan D; Huang SH; Truong R; Bosque A; Macedo AB; Kovacs C; Benko E; Eron JJ; Bosch RJ; Lalama CM; Simmens S; Walker BD; Mellors JW; Jones RB
    PLoS Pathog; 2017 Sep; 13(9):e1006629. PubMed ID: 28931091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
    Lee SA; Bacchetti P; Chomont N; Fromentin R; Lewin SR; O'Doherty U; Palmer S; Richman DD; Siliciano JD; Yukl SA; Deeks SG; Burbelo PD
    PLoS One; 2016; 11(8):e0160192. PubMed ID: 27483366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy.
    McManus M; Henderson J; Gautam A; Brody R; Weiss ER; Persaud D; Mick E; Luzuriaga K;
    Clin Infect Dis; 2019 May; 68(10):1725-1732. PubMed ID: 30668843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.
    Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M
    Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.